139 related articles for article (PubMed ID: 38703818)
1. Elevated neutrophils and reduced NK cells are associated with altered tear molecular signatures and clinical sequelae of chronic ocular Stevens-Johnson syndrome.
D'Souza S; Nair AP; Ashok N; Kannan R; Dickman MM; Nuijts RMMA; Shetty R; Sethu S; Ghosh A
Ocul Surf; 2024 May; 34():9-21. PubMed ID: 38703818
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-driven and interleukin-36γ-associated ocular surface inflammation in chronic Stevens-Johnson syndrome.
Koduri MA; Pingali T; Prasad D; Singh V; Singh S; Shanbhag SS; Basu S; Singh V
Allergy; 2024 Apr; ():. PubMed ID: 38682250
[TBL] [Abstract][Full Text] [Related]
3. Unique cytokine signature in ocular Stevens-Johnson syndrome non-responders.
Gurumurthy S; Srinivasan B; Agarwal S; Matai H; Angayarkanni N; Iyer G
Ocul Surf; 2024 Apr; 32():173-181. PubMed ID: 38490474
[TBL] [Abstract][Full Text] [Related]
4. Keratoconus patients exhibit a distinct ocular surface immune cell and inflammatory profile.
D'Souza S; Nair AP; Sahu GR; Vaidya T; Shetty R; Khamar P; Mullick R; Gupta S; Dickman MM; Nuijts RMMA; Mohan RR; Ghosh A; Sethu S
Sci Rep; 2021 Oct; 11(1):20891. PubMed ID: 34686755
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stage.
Ueta M; Nishigaki H; Sotozono C; Kinoshita S
BMJ Open Ophthalmol; 2017; 1(1):e000073. PubMed ID: 29354711
[TBL] [Abstract][Full Text] [Related]
6. Ocular surface cytokine profile in chronic Stevens-Johnson syndrome and its response to mucous membrane grafting for lid margin keratinisation.
Gurumurthy S; Iyer G; Srinivasan B; Agarwal S; Angayarkanni N
Br J Ophthalmol; 2018 Feb; 102(2):169-176. PubMed ID: 28689166
[TBL] [Abstract][Full Text] [Related]
7. Altered ocular surface immune cell profile in patients with dry eye disease.
Nair AP; D'Souza S; Shetty R; Ahuja P; Kundu G; Khamar P; Dadachanji Z; Paritekar P; Patel P; Dickman MM; Nuijts RM; Mohan RR; Ghosh A; Sethu S
Ocul Surf; 2021 Jul; 21():96-106. PubMed ID: 33862224
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with stevens-johnson syndrome and ocular cicatricial pemphigoid.
Arafat SN; Suelves AM; Spurr-Michaud S; Chodosh J; Foster CS; Dohlman CH; Gipson IK
Ophthalmology; 2014 Jan; 121(1):79-87. PubMed ID: 23962653
[TBL] [Abstract][Full Text] [Related]
9. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
De Rojas MV; Dart JK; Saw VP
Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase 9 is associated with conjunctival microbiota culture positivity in Korean patients with chronic Stevens-Johnson syndrome.
Moon J; Lee Y; Yoon CH; Kim MK
BMC Ophthalmol; 2022 Apr; 22(1):179. PubMed ID: 35440028
[TBL] [Abstract][Full Text] [Related]
11. Acute and Chronic Ophthalmic Involvement, Severity, and Sequelae in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Ganekal S; Nagarajappa A
Korean J Ophthalmol; 2021 Jun; 35(3):179-187. PubMed ID: 33596622
[TBL] [Abstract][Full Text] [Related]
12. Ocular surface involvement and histopathologic changes in the acute stage of Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional study.
Liu Y; Feng J; Ren Y; Shi W; Kang H; Peng Y; Tan Y; Wu R; Zhang G; He Y
BMC Ophthalmol; 2023 Jul; 23(1):297. PubMed ID: 37400766
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of tear film cytokines in Stevens-Johnson syndrome patients and comparative review of literature.
Koduri MA; Prasad D; Upadhyaya S; Jaffet J; Shanbhag SS; Basu S; Singh V
Sci Rep; 2021 Sep; 11(1):18433. PubMed ID: 34531438
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Treatment of Ophthalmic Sequelae of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at a Tertiary Eyecare Centre in Hungary.
Tóth G; Lukács A; Stachon T; Schirra F; Sándor GL; Nagy ZZ; Szentmáry N
Ophthalmol Ther; 2024 May; 13(5):1343-1356. PubMed ID: 38507192
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series.
Chow LLW; Ng ALK; Chow SSW; Choy BNK; Shih KC; Wong IYH; Chan JCY; Lai JSM
Int Ophthalmol; 2018 Jun; 38(3):1155-1160. PubMed ID: 28547534
[TBL] [Abstract][Full Text] [Related]
16. Multistep Grading System for Evaluation of Chronic Ocular Sequelae in Patients With Stevens-Johnson Syndrome.
Sharma N; Venugopal R; Maharana PK; Chaniyara M; Agarwal T; Pushker N; Pandey RM; Sangwan S; Sen S; Kashyap S; Sharma A; Khanna N; Vajpayee RB
Am J Ophthalmol; 2019 Jul; 203():69-77. PubMed ID: 30731084
[TBL] [Abstract][Full Text] [Related]
17. Severe Dry Eye With Combined Mechanisms is Involved in the Ocular Sequelae of SJS/TEN at the Chronic Stage.
Sotozono C; Ueta M; Yokoi N
Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES80-DES86. PubMed ID: 30481810
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications.
Ueta M
Front Med (Lausanne); 2021; 8():651247. PubMed ID: 34869401
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the ocular microbiome between chronic Stevens-Johnson syndrome patients and healthy subjects.
Kittipibul T; Puangsricharern V; Chatsuwan T
Sci Rep; 2020 Mar; 10(1):4353. PubMed ID: 32152391
[TBL] [Abstract][Full Text] [Related]
20. Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis.
Yoshikawa Y; Ueta M; Nishigaki H; Kinoshita S; Ikeda T; Sotozono C
Sci Rep; 2020 Nov; 10(1):18922. PubMed ID: 33144639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
